January 2016 - SK-Pharma invests one fifth of its global annual sales in research and development (R&D) of new innovative treatments and drugs.

September 2015 - Garan SK accelerates its emerging markets growth strategy with a portfolio of products in CIS and Latin America.

June 2015 - KS Kim significantly increases its portfolio and presence in the Israeli market.